Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2

被引:7
|
作者
Shaw, Briony [1 ,3 ]
Shortt, Jake [1 ,3 ]
Low, Michael [1 ,3 ]
Rogers, Benjamin [1 ,2 ]
Kaplan, Zane [1 ,3 ]
Fedele, Pasquale [1 ,3 ]
Gregory, Gareth [1 ,3 ]
Vilcassim, Shahla [1 ,3 ]
Gilbertson, Michael [1 ,3 ]
Grigoriadis, George [1 ,3 ]
Opat, Stephen [1 ,3 ]
机构
[1] Monash Hlth, Dept Clin Haematol, Melbourne, Vic, Australia
[2] Monash Hlth, Dept Infect Dis, Melbourne, Vic, Australia
[3] Monash Univ, Melbourne, Vic, Australia
关键词
COVID-19; haematological malignancy; haematological neoplasm; cancer; vaccination; COVID-19; MALIGNANCIES;
D O I
10.1111/imj.15954
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified.
引用
收藏
页码:2172 / 2175
页数:4
相关论文
共 50 条
  • [1] Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
    Oyaert, Matthijs
    De Scheerder, Marie-Angelique
    Van Herrewege, Sophie
    Laureys, Guy
    Van Assche, Sofie
    Cambron, Melissa
    Naesens, Leslie
    Hoste, Levi
    Claes, Karlien
    Haerynck, Filomeen
    Kerre, Tessa
    Van Laecke, Steven
    Van Biesen, Wim
    Jacques, Peggy
    Verhasselt, Bruno
    Padalko, Elizaveta
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US
    Zhao, Binghao
    Xia, Yu
    Ma, Wenbin
    JAMA ONCOLOGY, 2022, 8 (10) : 1515 - 1515
  • [3] SARS-CoV-2: To be or not to be vaccinated?
    Beauchet, Olivier
    MATURITAS, 2021, 147 : 64 - 65
  • [4] SARS-CoV-2 viral dynamics in immunocompromised patients
    Caillard, Sophie
    Benotmane, Ilies
    Gautier Vargas, Gabriela
    Perrin, Peggy
    Fafi-Kremer, Samira
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (04) : 1667 - 1669
  • [5] Viral dynamics of SARS-CoV-2 in immunocompromised patients
    Utzon, Andrea N.
    Johansen, Isik S.
    Bang, Line L.
    Pedersen, Rune M.
    Andersen, Thomas E.
    Madsen, Lone W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (08) : 1087.e1 - 1087.e3
  • [6] Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease
    Iluta, Sabina
    Pasca, Sergiu
    Dima, Delia
    Mester, Gabriela
    Urian, Laura
    Bojan, Anca
    Zdrenghea, Mihnea
    Trifa, Adrian
    Balacescu, Ovidiu
    Tomuleasa, Ciprian
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (06) : E8 - E8
  • [7] SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Reply
    Xu, Rong
    Berger, Nathan A.
    JAMA ONCOLOGY, 2022, 8 (10) : 1516 - 1517
  • [8] SARS-CoV-2 in immunocompromised individuals
    DeWolf, Susan
    Laracy, Justin C.
    Perales, Miguel-Angel
    Kamboj, Mini
    van den Brink, Marcel R. M.
    Vardhana, Santosha
    IMMUNITY, 2022, 55 (10) : 1779 - 1798
  • [9] Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients
    Korishettar, Ganesh
    Chikkahonnaiah, Prashanth
    Tulimilli, SubbaRao, V
    Dallavalasa, Siva
    Byrappa, Shashidhar H.
    Madhunapantula, SubbaRao, V
    Veeranna, Ravindra P.
    VACCINES, 2022, 10 (07)
  • [10] Inflammation markers as predictors of mortality in hospitalized patients infected with the SARS-COV-2
    Aguilar-Meza, J.
    Dulce Gonzalez, D.
    Orea-Tejeda, A.
    Rios-Pereda, A.
    Marquez-Cordero, J.
    Cornejo-Cornejo, L.
    Sanchez-Moreno, C.
    Salvatierra-Escobar, M.
    Lopez-Vasquez, I.
    Jimenez-Valentin, A.
    Salgado-Fernandez, M.
    Hernandez-Lopez, S.
    Hernandez-Urquieta, L.
    Robles-Hernandez, R.
    Hernandez-Zenteno, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 271 - 271